RPID Stock — Rapid Micro Biosystems Inc

Rapid Micro Biosystems Inc (RPID)

Updated October 16, 2026.

RPID is a Stock. Total return is -96.4% over the past 5.3 years, 184.7 points behind SPY at 88.3%.

Rapid Micro Biosystems is a life sciences technology company that provides automated microbial detection systems and software for quality control testing in pharmaceutical, biologics, medical device, and personal care manufacturing. The company's Growth Direct platform modernizes manual contamination testing workflows across applications including environmental monitoring, bioburden testing, and sterility release testing. As an operating company, it does not have a distribution frequency or yield profile.

RPID performance versus SPY

Price and return data through 2026-10-16.

Total return is -96.4% over the past 5.3 years, 184.7 points behind SPY at 88.3%. Over the past year its total return — price change plus distributions reinvested — is -74.0%. Its deepest 1-year drawdown was 83.7%.

RPID key facts

Asset type

Stock

Asset class

Equity

Inception date

07/15/2021

Distribution frequency

None

Last close

$0.76 (as of 2026-10-16)

Market cap

$34,884,261

Average volume

356700.0

Beta

1.505

Payout ratio

0.0%

EPS

$-1.11

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

RPID risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 83.7%.

Who may consider RPID — and who may not

It is a weaker fit for investors who need monthly cash flow (RPID does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on RPID

• All tickers starting with R

Tagged: Healthcare.

Frequently asked questions